ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 472 filers reported holding ASTRAZENECA PLC in Q1 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $45,808,206 | -41.0% | 587,360 | -48.7% | 0.06% | -48.3% |
Q1 2024 | $77,616,907 | +2726.5% | 1,145,637 | +2709.8% | 0.12% | +2260.0% |
Q4 2023 | $2,746,062 | +25.2% | 40,773 | +25.8% | 0.01% | +25.0% |
Q3 2023 | $2,194,196 | -86.8% | 32,401 | -86.1% | 0.00% | -87.9% |
Q2 2023 | $16,669,656 | -47.5% | 232,914 | -49.1% | 0.03% | -50.7% |
Q1 2023 | $31,730,712 | -80.0% | 457,149 | -80.4% | 0.07% | -81.2% |
Q4 2022 | $158,464,872 | +60.2% | 2,337,240 | +29.6% | 0.36% | +64.1% |
Q3 2022 | $98,894,000 | +0.1% | 1,803,331 | +20.6% | 0.22% | +6.9% |
Q2 2022 | $98,825,000 | -23.6% | 1,495,765 | -23.3% | 0.20% | -17.1% |
Q1 2022 | $129,411,000 | +9.0% | 1,950,719 | -4.3% | 0.24% | +11.9% |
Q4 2021 | $118,721,000 | +869.3% | 2,038,118 | +899.5% | 0.22% | +329.4% |
Q3 2021 | $12,248,000 | +144.4% | 203,916 | +143.7% | 0.05% | +121.7% |
Q2 2021 | $5,012,000 | -46.9% | 83,661 | -55.9% | 0.02% | -46.5% |
Q1 2021 | $9,434,000 | +500.1% | 189,745 | +503.4% | 0.04% | +377.8% |
Q4 2020 | $1,572,000 | -79.5% | 31,444 | -78.4% | 0.01% | -83.3% |
Q2 2020 | $7,682,000 | +125.0% | 145,242 | +90.0% | 0.05% | +58.8% |
Q1 2020 | $3,414,000 | -93.8% | 76,456 | -93.1% | 0.03% | -91.0% |
Q4 2019 | $54,955,000 | -34.6% | 1,102,192 | -41.5% | 0.38% | -42.8% |
Q3 2019 | $84,036,000 | -13.2% | 1,885,463 | -19.6% | 0.66% | -17.1% |
Q2 2019 | $96,819,000 | +84.7% | 2,345,410 | +80.9% | 0.80% | +222.7% |
Q1 2019 | $52,414,000 | +398.3% | 1,296,372 | +332.7% | 0.25% | +57.3% |
Q2 2018 | $10,519,000 | +52.1% | 299,591 | +47.3% | 0.16% | -48.5% |
Q2 2017 | $6,917,000 | -61.2% | 203,434 | -68.8% | 0.30% | +160.7% |
Q4 2016 | $17,827,000 | +125.9% | 652,522 | +171.7% | 0.12% | +108.9% |
Q3 2016 | $7,893,000 | +1722.9% | 240,186 | +1665.2% | 0.06% | +1020.0% |
Q3 2015 | $433,000 | -84.1% | 13,607 | -68.2% | 0.01% | -86.1% |
Q2 2015 | $2,725,000 | -62.1% | 42,776 | -59.3% | 0.04% | -61.7% |
Q1 2015 | $7,189,000 | -10.6% | 105,061 | -2.9% | 0.09% | -20.3% |
Q2 2014 | $8,042,000 | -73.9% | 108,220 | -77.2% | 0.12% | -78.9% |
Q1 2014 | $30,790,000 | – | 474,565 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |